The primary manufacturer of zolpidem, the active ingredient in Ambien and Ambien CR, is Sanofi-Aventis [1]. Zolpidem is a sedative-hypnotic medication used for the short-term treatment of insomnia [2].
Who Else Makes Zolpidem?
While Sanofi-Aventis is the originator, generic versions of zolpidem are manufactured by numerous pharmaceutical companies. These include, but are not limited to, Teva Pharmaceuticals, Mylan, and Accord Healthcare [3]. The availability of generic zolpidem means that multiple companies compete in the market for this medication.
When Did Zolpidem's Patent Expire?
The original patents for zolpidem tartrate, the salt form used in Ambien, have long expired [4]. The U.S. patent for zolpidem tartrate expired in 2007, opening the door for generic manufacturers to enter the market [4]. Extended-release formulations, such as Ambien CR, may have had separate patent protections that expired later [5]. Information on specific patent expiry dates for various zolpidem formulations and their authorized generics can be found on DrugPatentWatch.com [4][5].
What Are the Different Forms of Zolpidem Available?
Zolpidem is available in several forms to suit different treatment needs for insomnia. These include immediate-release tablets, extended-release tablets (Ambien CR), sublingual tablets (Edluar, Zolpimist), and oral spray (Zolpimist) [2]. Each formulation is designed to provide a different onset and duration of action [2].
What Are the Risks Associated with Zolpidem?
Like all medications, zolpidem carries potential risks. Common side effects include drowsiness, dizziness, and headache [2]. More serious side effects can include complex sleep behaviors such as sleepwalking, sleep-driving, and engaging in other activities while not fully awake, with no memory of the event [2]. There is also a risk of dependence and withdrawal symptoms, particularly with prolonged use [2].
How Does Zolpidem Compare to Other Sleep Medications?
Zolpidem is a non-benzodiazepine hypnotic, often referred to as a "Z-drug" [6]. It works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that calms brain activity [6]. Other classes of sleep medications include benzodiazepines, which have a higher risk of dependence and withdrawal, and antidepressants that are sometimes prescribed off-label for sleep [6]. The choice of sleep medication depends on individual patient factors, the type of insomnia, and physician recommendations [6].
What is the Mechanism of Action for Zolpidem?
Zolpidem selectively binds to specific GABA-A receptor subunits, primarily those containing the alpha-1 subunit, which are concentrated in the brain areas that regulate sleep [6]. This selective binding enhances GABA's inhibitory effects, leading to sedation and the promotion of sleep [6].
Sources
1. "Sanofi-Aventis." Wikipedia. Accessed October 26, 2023.
2. "Zolpidem Tartrate." National Institute of Diabetes and Digestive and Kidney Diseases. Accessed October 26, 2023.
3. "Zolpidem Tartrate." Drugs.com. Accessed October 26, 2023.
4. "Zolpidem Tartrate Patents." DrugPatentWatch.com. Accessed October 26, 2023.
5. "Ambien CR Patents." DrugPatentWatch.com. Accessed October 26, 2023.
6. "Insomnia Medications." National Institutes of Health. Accessed October 26, 2023.